Fatigue Management Guidelines

Initial Assessment and Severity

• The American College of Physicians recommends quantifying fatigue severity using a 0-10 numeric rating scale, with scores of 0-3 indicating mild fatigue and scores of 4-10 indicating moderate to severe fatigue that warrants a focused evaluation 1, 2
• Patients with moderate to severe fatigue (scores 4-10) should undergo a focused evaluation targeting treatable contributing factors, while those with mild fatigue (scores 0-3) require only education and periodic rescreening 1, 2
• The National Comprehensive Cancer Network recommends screening all patients using a numeric rating scale where 0 = no fatigue and 10 = worst fatigue imaginable 3, 1

Focused History and Red Flag Symptoms

• A focused history should document onset, pattern, duration, and changes in fatigue over time, as well as associated or alleviating factors, interference with normal functioning, and the patient's self-assessment of potential causes 1, 2
• Red flag symptoms, such as fever, drenching night sweats, unexplained weight loss, pain, pulmonary complaints, and unintentional weight loss, should be screened for in patients with moderate to severe fatigue 4
• The presence of lymphadenopathy, hepatosplenomegaly, or skin manifestations should also be documented in patients with moderate to severe fatigue 4

Laboratory Workup and Special Population Considerations

• The American College of Physicians recommends initial screening tests, including complete blood count with differential, comprehensive metabolic panel, thyroid-stimulating hormone, erythrocyte sedimentation rate, and C-reactive protein, for patients with moderate to severe fatigue (scores 4-10) 2, 4
• Special population considerations, such as new immigrants or recent travelers, should be assessed for tropical diseases, including malaria, tuberculosis, schistosomiasis, and dengue 4
• Cancer survivors should be considered for disease recurrence or late treatment effects 1

Management Approach and Follow-Up

• The American College of Physicians recommends initiating a structured physical activity program, improving sleep hygiene, and providing education and counseling for all patients with fatigue, regardless of cause 2, 3
• Identified contributing factors, such as depression, anxiety, pain, and nutritional deficiencies, should be managed effectively 1, 2, 4
• Regular follow-up visits and rescreening at regular intervals are recommended for effective long-term management and to monitor symptom evolution 2, 3

Fatigue Management in Adults

Assessment and Screening

• The National Comprehensive Cancer Network recommends screening for depression and anxiety in patients with fatigue using a validated tool, such as PHQ-9 or GAD-7, as depression is present in 25-33% of fatigued patients 5
• Sleep disturbance evaluation is essential, as sleep disturbances occur in 30-75% of fatigued patients, and screening for sleep apnea is recommended, particularly if the patient has gained weight or has other risk factors 5
• A comprehensive metabolic panel, including electrolytes, hepatic and renal function, is recommended for patients with moderate-to-severe fatigue (scores 4-10) 6

Management

• The National Comprehensive Cancer Network recommends addressing identified contributing factors, such as treating depression or anxiety if present, implementing cognitive behavioral therapy for insomnia, and optimizing pain management if applicable 5
• Referral to appropriate specialists is considered if fatigue persists despite addressing contributing factors and iron repletion, based on clinical findings 6

Evaluation and Management of Fatigue and Weight Gain

Initial Assessment and Medication Review

• The National Comprehensive Cancer Network recommends documenting all prescription medications, over-the-counter drugs, herbal supplements, and vitamins, and identifying recent medication changes that temporally correlate with symptom onset, as medications are a commonly overlooked contributor to fatigue 7
• The National Comprehensive Cancer Network suggests assessing for medications causing fatigue, such as β-blockers, SSRIs, and combinations of narcotics, antidepressants, antiemetics, and antihistamines, and considering dose adjustments or medication discontinuation when appropriate 7

Nutritional Assessment

• The National Comprehensive Cancer Network and the Journal of Clinical Oncology recommend documenting weight changes, current weight, and calculating body mass index, and evaluating caloric intake changes and impediments to nutritional intake 7, 8

Sleep and Mental Health Evaluation

• The National Comprehensive Cancer Network suggests evaluating for alcohol and substance abuse, which can lead to or aggravate sleep disturbance and fatigue 7

Physical Activity and Deconditioning Assessment

• The National Comprehensive Cancer Network recommends querying about functional status, including changes in exercise or activity patterns, and determining if patients can accomplish normal daily activities and participate in exercise programs 7

Diagnostic Approach to Chronic Fatigue

Initial Evaluation and Laboratory Workup

• The American Society of Clinical Oncology recommends using a 0-10 numeric rating scale to quantify fatigue severity, with scores of 4-10 indicating moderate to severe fatigue requiring focused evaluation 9
• Patients with fatigue scores ≥4 warrant comprehensive diagnostic assessment, including complete blood count with differential, comprehensive metabolic panel, and thyroid-stimulating hormone (TSH) levels 9

Management of Contributing Factors

• The National Comprehensive Cancer Network recommends assessing for fatigue-inducing medications, including β-blockers, SSRIs, narcotics, antidepressants, antiemetics, and antihistamines, and considering dose adjustments or discontinuation when appropriate 10
• Addressing identified comorbidities, including thyroid dysfunction, cardiac issues, or other medical conditions, is crucial for effective management 9, 10

Evaluation and Management of Moderate‑to‑Severe Fatigue in Older Adults

1. Assessment of Fatigue Severity

2. Focused Clinical History

3. Medication Review

4. Laboratory Workup (for scores ≥ 4)

5. Non‑Pharmacologic Management

5.1 Physical Activity

5.2 Education & Energy Conservation

5.3 Psychosocial Interventions (Category 1)

6. Specialist Referral Recommendations

NCCN Recommendations for the Evaluation and Monitoring of Fatigue

Initial Assessment of Fatigue Severity

Patients with mild fatigue (numeric rating 0–3) should receive education and periodic rescreening without further diagnostic workup. 13

Red‑Flag Evaluation

The presence of any red‑flag symptoms (fever, drenching night sweats, unexplained weight loss, pain, pulmonary complaints, lymphadenopathy, hepatosplenomegaly, or skin manifestations) mandates an extensive workup to rule out metastatic disease or serious comorbidities. 13

Additional Testing Based on Clinical Context

Both recommendations are derived from NCCN guidance. 13

Imaging Considerations

Imaging studies (chest X‑ray, CT, PET/CT) should be reserved for patients with red‑flag symptoms; they are not indicated for mild‑to‑moderate fatigue persisting 6–12 months after therapy completion in the absence of other concerning findings. 13

Follow‑Up and Monitoring

Inpatients should be screened for fatigue daily, whereas outpatients should be screened at each routine follow‑up visit. 14
Fatigue monitoring should continue after treatment completion because symptoms may persist beyond therapy. 14